医学伦理研究助手
前沿
论文精读

论文 · 综述

CRISPR编辑蔬菜作物的分子靶点与性状创新:2020—2026年最新综述

Plants (Basel) · 2026年9月21日 · Deligiannidou 等 3 位作者

问这篇
一分钟了解要点综述汇总2020至2026年CRISPR编辑番茄、马铃薯等蔬菜作物的靶点与性状进展。

不需要生物学背景,多打比方

正在获取全文并生成讲解(拿不到全文就依据摘要)…

已等待 0 秒大约需要 10–20 秒

可以先看别的,做好了会自动出现在这里。

这篇还没有动画

动画会把研究的流程、作用机制和关键结果一步一步演示出来,每一步都标明出自原文哪里。制作大约需要一两分钟。

目前只拿到了摘要全文暂时拿不到(可能不是免费全文)。下面是论文摘要。

摘要Abstract

摘要第 1 段问这一段

Vegetable crops are of fundamental nutritional and economic importance worldwide, yet their improvement through conventional breeding remains time consuming and constrained by genomic complexity. For that reason, over the period 2020-2026, CRISPR/Cas-mediated genome editing, a new genomic technique (NGT), has emerged as the leading tool for precise, rapid and targeted modification of vegetable crop genomes. In this review, we summarize selected peer-reviewed studies on CRISPR/Cas applications across a broad range of vegetable species. Tomato (Solanum lycopersicum) and potato (Solanum tuberosum) are the most edited species with the CRISPR/Cas system, with tomato being at the forefront, while other crops such as cucumber, watermelon, Brassica species, pepper, eggplant and lettuce, follow. We studied eight trait categories that have been improved, namely biotic stress resistance, abiotic stress resistance, yield and growth regulation, food/feed quality modification, color/flavor modification, storage conditions, herbicide resistance and industrial utilization. Out of these, biotic stress resistance is the most actively targeted category across both tomato and potato, with viral, fungal, bacterial and oomycete pathogens being addressed through the editing of host susceptibility genes. Some advances include editing SlDMR6-1 and DMR6 orthologs to confer broad-spectrum disease resistance, multiplex editing of the MLO gene family to achieve powdery mildew resistance, the utilization of the CRISPR/Cas13 system to confer resistance in RNA viruses in potato, and the engineering of drought-tolerant and quality-improved varieties across multiple species. Finally, the regulatory landscape for genome-edited products in the European Union is currently evolving with efforts to distinguish them from genome-modified products and drive further growth for the field.

这篇对您:
讲解或动画有问题: